Our Solution

The Aspida Dx system can be operated by minimally trained personnel. The saliva sample collection is noninvasive and does not require gender-matched witnessing and can be obtained in an open space.

The collection device has a visual indicator to inform the operator that a sufficient volume of saliva has been collected. The sample is stored in two separate compartments. The first one is used immediately by the Aspida Dx system and the second sample stored in the second compartment with a preservative is locked. The secondary sample can be used for confirmatory testing, if necessary under a chain of custody protocol.

The operator needs only to collect the sample from the individual, then cap the collection cartridge, introduce the cartridge in the reader and press run.

The test menu is designed to detect most currently used drugs based on intelligence from CFSRE(1) and NMS Labs(2). Through its supply chain,  AspidaDx is able to coordinate the development of the reagents required  to detect these substances, and its  cartridge manufacturing technology enables the company to rapidly adapt to current requirements. In its current configuration, the silicon optical waveguide that is the core sensing technology in the AspidaDx cartridge can distinguish 36 chemical signals that permit the detection of multiple targeted compounds and also provide the required quality control information that ensures the system is mistake proof.